Journal of the Neurological Sciences 1993: Vol 117 Index

5 Pages·1993·1.3 MB·English

Journal of the Neurological Sciences, 117 (1993) 246-249
Elsevier Science Publishers B.V.
Author Index (Vol. 117)
Aguera, M., see Antoine, J.C. (117) 215 Dahlin, M., Knutsson, E. and Nergardh, A.
Albert, P.S., see Elovaara, I. (117) 111 Treatment of spasticity in children with low dose benzodiazepine
Ambrogini, P., see Cuppini, R. (117) 61 (117) 54
Antoine, J.C., Honnorat, J., Vocanson, C., Koenig, F., Aguera, M., Dalton, A.J., see Mehta, P.D. (117) 186
Belin, M.F. and Michel, D. De la Porte, S., Ragueh, F., Eymard, B., Courbin, P., Chapron, J.
Posterior uveitis, paraneoplastic encephalomyelitis and auto-anti- and Koenig, J. ;
bodies reacting with developmental protein of brain and retina Effect of sera from myasthenia gravis patients and of a-
(117) 215 bungarotoxin on acetylcholinesterase during in vitro neuromuscu-
Archelos, J.J., Roggenbuck, K., Schneider-Schaulies, J., Toyka, K.V. lar synaptogenesis (117) 92
and Hartung, H.-P. Del Grande, P., see Cuppini, R. (117) 61
Detection and quantification of antibodies to the extracellular Doyu, M., see Sobue, G. (117) 74
domain of PO during experimental allergic neuritis (117) 197
Eiman, D., see Rohowsky-Kochan, C. (117) 120
Ekre, H.-P., see Olsson, T. (117) 130
Barkhof, F., Scheltens, P. and Kamphorst, W. Elovaara, I., Albert, P.S., Ranki, A., Krohn, K. and Seppaila, I.
Pre- and post-mortem MR imaging of unsuspected multiple scle- HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and
rosis in a patient with Alzheimer’s disease (117) 175 IgG1-G4 antibodies in relation to clinical disease (117) 111
Barquero, M.S., see Benitez, J. (117) 8 Erasmi-K6rber, H., see Kolbinger, R. (117) 232
Battistel, A., see Prelle, A. (117) 24 Eymard, B., see De la Porte, S. (117) 92
Belin, M.F., see Antoine, J.C. (117) 215
Bellander, B.-M., see Meller, D. (117) 164 Fernandez-Sola, J., Cusso, R., Picado, C., Vernet, M., Grau, J.M.
Benach, J.L., see Garcia Moncé, J.C. (117) 206 and Urbano-Marquez, A.
Benitez, J., Barquero, M.S., Coria, F., Molina, J.A., Jiménez-Jiménez, Patients with chronic glucocorticoid treatment develop changes in
F.J. and Ladero, J.M. muscle glycogen metabolism (117) 103
Oxidative polymorphism of debrisoquine is not related to the risk Fitzhugh, E.C., see Wang, M.Q. (117) 107
of Alzheimer’s disease (117) 8 Furie, R.A., see Garcia Moncé, J.C. (117) 206
Bergmans, P.L.M., see Kuiper, M.A. (117) 41
Bordoni, A., see Prelle, A. (117) 24 Garcia Moncé, J.C., Wheeler, C.M., Benach, J.L., Furie, R.A., Luke-
Bosch, D.A., see Van Someren, E.J.W. (117) 16 hart, S.A., Stanek, G. and Steere, A.C.
Bresolin, N., see Prelle, A. (117) 24 Reactivity of neuroborreliosis patients (Lyme disease) to cardi-
Byrne, E., see Sudoyo, H. (117) 83 olipin and gangliosides (117) 206
Goto, I., see Kira, J.-i. (117) 179
Grau, J.M., see Fernandez-Sola, J. (117) 103
Cecchini, T., see Cuppini, R. (117) 61
Challa, V.R., Moody, D.M. and Troost, B.T. Hartung, H.-P., see Archelos, J.J. (117) 197
Brain embolic phenomena associated with cardiopulmonary by- Hashizume, Y., see Kume, A. (117) 33
pass (117) 224 Hasuo, K., see Kira, J.-i. (117) 179
Chapron, J., see De la Porte, S. (117) 92 Heindel, W., see Kolbinger, R. (117) 232
Checcarelli, N., see Prelle, A. (117) 24 H6jeberg, B., see Olsson, T. (117) 130
Chen, H., see Zhang, Z.G. (117) 240 Honnorat, J., see Antoine, J.C. (117) 215
Chopp, M., see Zhang, Z.G. (117) 240 Hoogbergen, M.M., see Van der Wey, L.P. (117) 79
Chu, N.-S. and Hung, T.-P. Hung, T.-P., see Chu, N.-S. (117) 1
Geographic variations in Wilson’s disease (117) 1
Ciaroni, S., see Cuppini, R. (117) 61 Ingvar, M., see Meller, D. (117) 164
Comi, G., see Prelle, A. (117) 24 Ishikawa, A. and Miyatake, T.
Cook, $.D., see Rohowsky-Kochan, C. (117) 120 Effects of smoking in patients with early-onset Parkinson’s dis-
Coria, F., see Benitez, J. (117) 8 ease (117) 28
Cornelius, C.-P., see Wiethdlter, H. (117) 68 Iwamoto, H., see Yoshizawa, T. (117) 12
Courbin, P., see De la Porte, S. (117) 92
Cuppini, R., Cecchini, T., Ciaroni, S., Ambrogini, P. and Del Grande, Jiménez-Jiménez, F.J., see Benitez, J. (117) 8
P,
Nodal and terminal sprouting by regenerating nerve in vitamin Kachi, T., see Sobue, G. (117) 74
E-deficient rats (117) 61 Kamphorst, W., see Barkhof, F. (117) 175
Cusso, R., see Fernandez-Sola, J. (117) 103 Kanazawa, I., see Yoshizawa, T. (117) 12
Journal of the Neurological Sciences, 117 (1993) 246-249
Elsevier Science Publishers B.V.
Author Index (Vol. 117)
Aguera, M., see Antoine, J.C. (117) 215 Dahlin, M., Knutsson, E. and Nergardh, A.
Albert, P.S., see Elovaara, I. (117) 111 Treatment of spasticity in children with low dose benzodiazepine
Ambrogini, P., see Cuppini, R. (117) 61 (117) 54
Antoine, J.C., Honnorat, J., Vocanson, C., Koenig, F., Aguera, M., Dalton, A.J., see Mehta, P.D. (117) 186
Belin, M.F. and Michel, D. De la Porte, S., Ragueh, F., Eymard, B., Courbin, P., Chapron, J.
Posterior uveitis, paraneoplastic encephalomyelitis and auto-anti- and Koenig, J. ;
bodies reacting with developmental protein of brain and retina Effect of sera from myasthenia gravis patients and of a-
(117) 215 bungarotoxin on acetylcholinesterase during in vitro neuromuscu-
Archelos, J.J., Roggenbuck, K., Schneider-Schaulies, J., Toyka, K.V. lar synaptogenesis (117) 92
and Hartung, H.-P. Del Grande, P., see Cuppini, R. (117) 61
Detection and quantification of antibodies to the extracellular Doyu, M., see Sobue, G. (117) 74
domain of PO during experimental allergic neuritis (117) 197
Eiman, D., see Rohowsky-Kochan, C. (117) 120
Ekre, H.-P., see Olsson, T. (117) 130
Barkhof, F., Scheltens, P. and Kamphorst, W. Elovaara, I., Albert, P.S., Ranki, A., Krohn, K. and Seppaila, I.
Pre- and post-mortem MR imaging of unsuspected multiple scle- HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and
rosis in a patient with Alzheimer’s disease (117) 175 IgG1-G4 antibodies in relation to clinical disease (117) 111
Barquero, M.S., see Benitez, J. (117) 8 Erasmi-K6rber, H., see Kolbinger, R. (117) 232
Battistel, A., see Prelle, A. (117) 24 Eymard, B., see De la Porte, S. (117) 92
Belin, M.F., see Antoine, J.C. (117) 215
Bellander, B.-M., see Meller, D. (117) 164 Fernandez-Sola, J., Cusso, R., Picado, C., Vernet, M., Grau, J.M.
Benach, J.L., see Garcia Moncé, J.C. (117) 206 and Urbano-Marquez, A.
Benitez, J., Barquero, M.S., Coria, F., Molina, J.A., Jiménez-Jiménez, Patients with chronic glucocorticoid treatment develop changes in
F.J. and Ladero, J.M. muscle glycogen metabolism (117) 103
Oxidative polymorphism of debrisoquine is not related to the risk Fitzhugh, E.C., see Wang, M.Q. (117) 107
of Alzheimer’s disease (117) 8 Furie, R.A., see Garcia Moncé, J.C. (117) 206
Bergmans, P.L.M., see Kuiper, M.A. (117) 41
Bordoni, A., see Prelle, A. (117) 24 Garcia Moncé, J.C., Wheeler, C.M., Benach, J.L., Furie, R.A., Luke-
Bosch, D.A., see Van Someren, E.J.W. (117) 16 hart, S.A., Stanek, G. and Steere, A.C.
Bresolin, N., see Prelle, A. (117) 24 Reactivity of neuroborreliosis patients (Lyme disease) to cardi-
Byrne, E., see Sudoyo, H. (117) 83 olipin and gangliosides (117) 206
Goto, I., see Kira, J.-i. (117) 179
Grau, J.M., see Fernandez-Sola, J. (117) 103
Cecchini, T., see Cuppini, R. (117) 61
Challa, V.R., Moody, D.M. and Troost, B.T. Hartung, H.-P., see Archelos, J.J. (117) 197
Brain embolic phenomena associated with cardiopulmonary by- Hashizume, Y., see Kume, A. (117) 33
pass (117) 224 Hasuo, K., see Kira, J.-i. (117) 179
Chapron, J., see De la Porte, S. (117) 92 Heindel, W., see Kolbinger, R. (117) 232
Checcarelli, N., see Prelle, A. (117) 24 H6jeberg, B., see Olsson, T. (117) 130
Chen, H., see Zhang, Z.G. (117) 240 Honnorat, J., see Antoine, J.C. (117) 215
Chopp, M., see Zhang, Z.G. (117) 240 Hoogbergen, M.M., see Van der Wey, L.P. (117) 79
Chu, N.-S. and Hung, T.-P. Hung, T.-P., see Chu, N.-S. (117) 1
Geographic variations in Wilson’s disease (117) 1
Ciaroni, S., see Cuppini, R. (117) 61 Ingvar, M., see Meller, D. (117) 164
Comi, G., see Prelle, A. (117) 24 Ishikawa, A. and Miyatake, T.
Cook, $.D., see Rohowsky-Kochan, C. (117) 120 Effects of smoking in patients with early-onset Parkinson’s dis-
Coria, F., see Benitez, J. (117) 8 ease (117) 28
Cornelius, C.-P., see Wiethdlter, H. (117) 68 Iwamoto, H., see Yoshizawa, T. (117) 12
Courbin, P., see De la Porte, S. (117) 92
Cuppini, R., Cecchini, T., Ciaroni, S., Ambrogini, P. and Del Grande, Jiménez-Jiménez, F.J., see Benitez, J. (117) 8
P,
Nodal and terminal sprouting by regenerating nerve in vitamin Kachi, T., see Sobue, G. (117) 74
E-deficient rats (117) 61 Kamphorst, W., see Barkhof, F. (117) 175
Cusso, R., see Fernandez-Sola, J. (117) 103 Kanazawa, I., see Yoshizawa, T. (117) 12
247
Kastrukoff, L.F., Lau, A.S., Leung, G.Y. and Thomas, E.E. Olsson, T., Sun, J.-B., Solders, G., Xiao, B.-G., Héjeberg, B., Ekre,
Contrasting effects of immunosuppression on herpes simplex H.-P. and Link, H.
virus type I (HSV I) induced central nervous system (CNS) Autoreactive T and B cell responses to myelin antigens after
demyelination in mice (117) 148 diagnostic sural nerve biopsy (117) 130
Kira, J.-i., Tobimatsu, S., Goto, I. and Hasuo, K.
Primary progressive versus relapsing remitting multiple sclerosis Pawlik, G., see Kolbinger, R. (117) 232
in Japanese patients: a combined clinical, magnetic resonance Percy, M.E., see Mehta, P.D. (117) 186
imaging and multimodality evoked potential study (117) 179 Picado, C., see Fernandez-Sola, J. (117) 103
Knutsson, E., see Dahlin, M. (117) 54 Polder, T.W., see Van der Wey, L.P. (117) 79
Koenig, F., see Antoine, J.C. (117) 215 Prelle, A., Moggio, M., Checcarelli, N., Comi, G., Bresolin, N.,
Koenig, J., see De la Porte, S. (117) 92 Battistel, A., Bordoni, A. and Scarlato, G.
Koeppen, A.H., see Willers, I. (117) 159 Multiple deletions of mitochondrial DNA in a patient with peri-
Kolbinger, R., Heindel, W., Pawlik, G. and Erasmi-K6rber, H. odic attacks of paralysis (117) 24
Right proatlantal artery type I, right internal carotid occlusion,
and left internal carotid stenosis: case report and review of the
Ragueh, F., see De la Porte, S. (117) 92
literature (117) 232
Ranki, A., see Elovaara, I. (117) 111
Komatsuzaki, Y., see Yoshizawa, T. (117) 12
Reder, A.T. and Lowy, M.T.
Kondo, K., see Neilson, S. (117) 46
Serum prolactin levels in active multiple sclerosis and during
Konings, C.H., see Kuiper, M.A. (117) 41
cyclosporin treatment (117) 192
Krohn, K., see Elovaara, I. (117) 111
Ressler, B., see Willers, I. (117) 159
Kriiger, J., see Wiethdlter, H. (117) 68
Robinson, I., see Neilson, S. (117) 46
Kuiper, M.A., Konings, C.H., Bergmans, P.L.M. and Wolters, E.C.
Roggenbuck, K., see Archelos, J.J. (117) 197
Whole blood monoamine oxidase activity in Parkinson’s disease
Rohowsky-Kochan, C., Eiman, D. and Cook, S.D.
and multiple system atrophy patients (117) 41
Individual specific bias usage of HLA-DR antigens in the restric-
Kumagai, T., see Sobue, G. (117) 74
tion of myelin basic protein-reactive T cell clones (117) 120
Kume, A., Takahashi, A. and Hashizume, Y.
Neuronal cell loss of the striatonigral system in multiple system
Scarlato, G., see Prelle, A. (117) 24
atrophy (117) 33
Scheltens, P., see Barkhof, F. (117) 175
Schmidt-Kastner, R., see Meller, D. (117) 164
Ladero, J.M., see Benitez, J. (117) 8
Schneider-Schaulies, J., see Archelos, J.J. (117) 197
Lau, A.S., see Kastrukoff, L.F. (117) 148
Seppaila, I., see Elovaara, I. (117) 111
Leung, G.Y., see Kastrukoff, L.F. (117) 148
Sersen, E.A., see Mehta, P.D. (117) 186
Li, Y., see Wang, M.Q. (117) 107
Shea, J., see Wang, M.Q. (117) 107
Link, H., see Olsson, T. (117) 130
Singh, S., see Willers, I. (117) 159
Lowy, M.T., see Reder, A.T. (117) 192
Sobue, G., Doyu, M., Kachi, T., Yasuda, T., Mukai, E., Kumagai, T.
Lukehart, S.A., see Garcia Moncé, J.C. (117) 206
and Mitsuma, T.
Subclinical phenotypic expressions in heterozygous females of
Mahoney, B.S., see Wang, M.Q. (117) 107
X-linked recessive bulbospinal neuronopathy (117) 74
Marzuki, S., see Sudoyo, H. (117) 83
Solders, G., see Olsson, T. (117) 130
Mastaglia, F., see Sudoyo, H. (117) 83
Spauwen, P.H.M., see Van der Wey, L.P. (117) 79
Matsuda, M., see Tsukada, N. (117) 140
Speelman, J.D., see Van Someren, E.J.W. (117) 16
Mehta, P.D., Dalton, A.J., Mehta, S.P., Percy, M.E., Sersen, E.A.
Stanek, G., see Garcia Moncé, J.C. (117) 206
and H.M. Wisniewski,
Steere, A.C., see Garcia Moncé, J.C. (117) 206
Immunoglobulin G subclasses in older persons with Down syn-
Sudoyo, H., Marzuki, S., Byrne, E. and Mastaglia, F.
drome (117) 186
Phenotypic expression of mtDNA heteroplasmy in the skeletal
Mehta, S.P., see Mehta, P.D. (117) 186
muscle of patients with oculomyopathy: defect in mitochondrial
Meller, D., Bellander, B.-M., Schmidt-Kastner, R. and Ingvar, M.
protein synthesis (117) 83
Immunohistochemical studies with antibodies to neurofilament
Sun, J.-B., see Olsson, T. (117) 130
proteins on axonal damage in experimental focal lesions in rat
Swaab, D.F., see Van Someren, E.J.W. (117) 16
(117) 164
Melville, C., see Wiethdlter, H. (117) 68
Michel, D., see Antoine, J.C. (117) 215 Takahashi, A., see Kume, A. (117) 33
Mirmiran, M., see Van Someren, E.J.W. (117) 16 Thomas, E.E., see Kastrukoff, L.F. (117) 148
Tobimatsu, S., see Kira, J.-i. (117) 179
Mitsuma, T., see Sobue, G. (117) 74
Miyagi, K., see Tsukada, N. (117) 140 Toyka, K.V., see Archelos, J.J. (117) 197
Troost, B.T., see Challa, V.R. (117) 224
Miyatake, T., see Ishikawa, A. (117) 28
Mizusawa, H., see Yoshizawa, T. (117) 12 Tsukada, N., Matsuda, M., Miyagi, K. and Yanagisawa, N.
Moggio, M., see Prelle, A. (117) 24 Cytotoxicity of T cells for cerebral endothelium in multiple scle-
rosis (117) 140
Molina, J.A., see Benitez, J. (117) 8
Moody, D.M., see Challa, V.R. (117) 224
Mukai, E., see Sobue, G. (117) 74 Urbano-Marquez, A., see Fernandez-Sola, J. (117) 103
Neilson, S., Robinson, I. and Kondo, K. Van der Wey, L.P., Polder, T.W., Hoogbergen, M.M. and Spauwen,
A new analysis of mortality from motor neurone disease in Japan, P.H.M.
1950-1990: rise and fall in the postwar years (117) 46 A model for monitoring nerve blood flow during expansion by
Nergardh, A., see Dahlin, M. (117) 54 laser Doppler flowmetry in the rabbit (117) 79
Nicholson, M.E., see Wang, M.Q. (117) 107 Van Gool, W.A., see Van Someren, E.J.W. (117) 16
248
Van Someren, E.J.W., Van Gool, W.A., Vonk, B.F.M., Mirmiran, cell proliferation of fibroblasts in patients with Friedreich’s ataxia
M., Speelman, J.D., Bosch, D.A. and Swaab, D.F. (117) 159
Ambulatory monitoring of tremor and other movements before Wisniewski, H.M., see Mehta, P.D. (117) 186
and after thalamotomy: a new quantitative technique (117) 16 Wolters, E.C., see Kuiper, M.A. (117) 41
Vernet, M., see Fernandez-Sola, J. (117) 103
Vocanson, C., see Antoine, J.C. (117) 215 Xiao, B.-G., see Olsson, T. (117) 130
Vonk, B.F.M., see Van Someren, E.J.W. (117) 16
Yanagisawa, N., see Tsukada, N. (117) 140
Wang, M.Q., Nicholson, M.E., Mahoney, B.S., Li, Y., Fitzhugh, E.C. Yasuda, T., see Sobue, G. (117) 74
and Shea, J. Yoshizawa, T., Komatsuzaki, Y., Iwamoto, H., Mizusawa, H. and
The effects of high and low BACs on the Hoffmann reflex (117) Kanazawa, I.
107 Screening of the mis-sense mutation producing the 7!’Val > Ile
Wheeler, C.M., see Garcia Moncé, J.C. (117) 206 substitution in the amyloid precursor protein in Japanese familial
Wiethdliter, H., Kriger, J., Melville, C. and Cornelius, C.-P. and sporadic Alzheimer’s disease (117) 12
Photochemically induced experimental ischemic neuropathy: a
clinical, electrophysiological and immunohistochemical study Zhang, Z.G., Chopp, M. and Chen, H.
(117) 68 Duration dependent post-ischemic hypothermia alleviates cortical
Willers, I., Ressler, B., Singh, S. and Koeppen, A.H. damage after transient middle cerebral artery occlusion in the rat
Immunocytochemical studies on the vimentin distribution and (117) 240
Subject Index (Vol. 117)
Acetylcholine receptor, (117) 92 Debrisoquine, (117) 8
Acetylcholinesterase, (117) 92 Dementia, (117) 175
Alcohol intoxication, (117) 107 Dementia of Alzheimer type, (117) 186
Alkaline phosphatase, (117) 224 mtDNA deletions, (117) 83
Alzheimer’s disease, (117) 8, (117) 12, (117) 175 mtDNA multiple deletions, (117) 24
Ambulatory monitoring, (117) 16 mtDNA mutations, (117) 83
Amyloid precursor protein gene, (117) 12 Dopamine, (117) 28, (117) 41
Androgen receptor gene, (117) 74 Down syndrome, (117) 186
Athymic mice, (117) 148 DR antigens, (117) 120
Auto-antibodies, (117) 197 Drug polymorphism, (117) 8
Autoantibodies, (117) 215
Early-onset Parkinson’s disease, (117) 28
Autoimmunity, (117) 130
Electrophysiological investigation, (117) 1
Axonal damage, (117) 164
Emboli, (117) 224
Embryo, (117) 215
BAC curve, (117) 107
EMG, (117) 107
Beige mice, (117) 148
Benzodiazepine, (117) 54 Encephalomyelitis, (117) 215
Endothelial cell, (117) 140
Brain, (117) 215, (117) 224
End-plate, (117) 61
a-Bungarotoxin, (117) 92
Enzyme linked immunosorbent assay, (117) 186
Cardiolipin, (117) 206 Experimental ischemic neuropathy, (117) 68
Extensor digitorum longus muscle, (117) 61
Cardiopulmonary bypass, (117) 224
Extracellular domain, (117) 197
Carotid endarterectomy, (117) 232
Catecholamine, (117) 28 Familial Alzheimer’s disease, (117) 12
Cell culture, (117) 159 Fixed human brain, (117) 175
Cell proliferation, (117) 159 Focal cortical lesion, (117) 164
Central nervous system demyelination, (117) 148 Friedreich’s ataxia, (117) 159
Cerebral angiography, (117) 232
Cerebral arteries, embryology, (117) 232 Gangliosides, (117) 206
Cerebral palsy, (117) 54 GBS, (117) 197
Cerebrospinal fluid, (117) 111 Genetic pattern, (117) 1
Cerebrovascular disorders, (117) 232 Geographic variation, (117) 1
Children, (117) 54 Glucocorticoid, (117) 103
Copper metabolism, (117) 1 Glycogen, (117) 103
Cyclophosphamide, (117) 148 Glycogen metabolism, (117) 103
Cyclosporin A, (117) 148, (117) 192 Glycogen phosphorylase, (117) 103
CYP2D6, (117) 8 Glycogen synthase, (117) 103
Cytotoxic T cell, (117) 140 Gompertzian analysis, (117) 46
Herpes simplex virus, (117) 148 Parkinson’s disease, (117) 16, (117) 28, (117) 41
Heterozygous female, (117) 74 Pathology, (117) 33
HIV-1 encephalopathy, (117) 111 Periodic paralysis, (117) 24
HIV-1 infection, (117) 111 Peripheral nerve, (117) 79
HIV-1-specific IgG, IgM, IgG1-IgG4 antibodies, (117) 111 Phenotypic expression, (117) 74
Hoffmann reflex, (117) 107 Photothrombosis, (117) 68
H-reflex, (117) 107 P45011D6, (117) 8
Platelets, (117) 41
IgG subclasses, (117) 186 Polymerase chain reaction, (117) 12
Immature cell, (117) 215 Polyneuropathy, (117) 130
Immune regulation, (117) 192 Post-ischemic hypothermia, (117) 240
Immunocytochemistry, (117) 159 Proatlantal artery type I, (117) 232
Immunohistochemistry, (117) 164 Prolactin, (117) 192
Immunosuppression, (117) 148
Interferon-y, (117) 130 Racial modification, (117) 179
Isotope release, (117) 140 Rats, (117) 240
Respiratory enzymes deficiency, (117) 83
Japan, (117) 46 Restriction enzyme polymorphism, (117) 12
Retina, (117) 215
Laser Doppler flowmetry, (117) 79 Risk factors, (117) 8
Leucoencephalopathy, (117) 175 Rose bengal, (117) 68
Low dose, (117) 54
Serum, (117) 111
Magnetic resonance imaging, (117) 175, (117) 179 Smoking, (117) 28
Major histocompatibility complex (MHC), (117) 140 Socio-economic problems, (117) 1
MAO-B, (117) 41 Spasticity, (117) 54
MHC restriction, (117) 120 Status epilepticus, (117) 164
Mis-sense mutation, (117) 12 Steroid myopathy, (117) 103
Mitochondrial DNA, (117) 83 Striatonigral degeneration, (117) 33
Mitochondrial myopathy, (117) 24 Striatum, (117) 33
Mitochondrial protein synthesis, (117) 83 Stroke, (117) 224
Monoamine oxidase, (117) 41 Substantia nigra, (117) 33
Mortality, (117) 46 Susceptibility, (117) 46
Motor neurone disease, (117) 46
Movement, (117) 16 Target-effector cell ratio, (117) 140
Multimodality evoked potentials, (117) 179 T cell clones, (117) 120
Multiple sclerosis, (117) 140, (117) 175, (117) 179, (117) 192 Terminal sprouting, (117) 61
Multiple system atrophy, (117) 33, (117) 41 Thalamotomy, (117) 16
Muscle reinnervation, (117) 61 Transient MCA occlusion, (117) 240
Myasthenia gravis, (117) 92 Treatment, (117) 54
Myelin associated glycoprotein, (117) 130 Tremor, (117) 16
Myelin basic protein, (117) 120, (117) 130 Type 2 fiber atrophy, (117) 103
Nerve blood flow, (117) 79 Uveitis, (117) 215
Nerve expansion, (117) 79
Nerve-muscle cultures, (117) 92 Vertebral arteries, abnormalities, (117) 232
Nerve regeneration, (117) 61 Vimentin, (117) 159
Neuritis, (117) 197 Vitamin E, (117) 61
Neuroborreliosis, (117) 206
Neurofilament protein, (117) 164 Walking tracks, (117) 68
Nicotine, (117) 28 White matter degeneration, (117) 1
Nodal sprouting, (117) 61 Whole blood, (117) 41
Wilson’s disease, (117) 1
Py, (117) 130
P,, (117) 130 X-irradiation, (117) 148
PO, (117) 197 X-linked recessive bulbospinal neuronopathy, (117) 74
Paraneoplastic syndrome, (117) 215